These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7841423)

  • 1. Drug-resistant tuberculosis: issues in epidemiology and challenges for public health.
    Rieder HL
    Tuber Lung Dis; 1994 Oct; 75(5):321-3. PubMed ID: 7841423
    [No Abstract]   [Full Text] [Related]  

  • 2. High frequency of multidrug-resistant Mycobacterium tuberculosis isolates in Georgetown, Guyana.
    Menner N; Günther I; Orawa H; Roth A; Rambajan I; Wagner J; Hahn H; Persaud S; Ignatius R
    Trop Med Int Health; 2005 Dec; 10(12):1215-8. PubMed ID: 16359400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDR-TB: a challenge for the 21st century.
    Petryszyn K; LeLacheur S
    JAAPA; 2002 Apr; 15(4):51-2, 57-8, 63-4 passim; quiz 65-6. PubMed ID: 12012587
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1995 Aug; 37(954):67-70. PubMed ID: 7616907
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycobacterium tuberculosis drug resistance: a call to action.
    Sudre P; Cohn DL
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):609-11. PubMed ID: 9712272
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and epidemiological characteristics of patients with drug-resistant tuberculosis].
    Okulovskaia SS; Gurevich GL; Bogomazova AV
    Probl Tuberk; 1999; (6):6-8. PubMed ID: 10715945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High initial and acquired drug resistance in pulmonary tuberculosis in Turkey.
    Tahaoğlu K; Kizkin O; Karagöz T; Tor M; Partal M; Sadoğlu T
    Tuber Lung Dis; 1994 Oct; 75(5):324-8. PubMed ID: 7841424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance among tuberculosis patients, New York City, 1991 and 1992.
    Driver CR; Frieden TR; Bloch AB; Onorato IM
    Public Health Rep; 1994; 109(5):632-6. PubMed ID: 7938383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug susceptibility profiling of tuberculous meningitis.
    Nagarathna S; Rafi W; Veenakumari HB; Mani R; Satishchandra P; Chandramuki A
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):105-7. PubMed ID: 18173886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-resistant Mycobacterium tuberculosis in California, 1991 to 1992.
    Koo D; Royce S; Rutherford GW
    West J Med; 1995 Nov; 163(5):441-5. PubMed ID: 8533406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 14. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-resistant tuberculosis: reality and potential threat.
    Lalloo UG
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):255-8. PubMed ID: 20132610
    [No Abstract]   [Full Text] [Related]  

  • 16. [The resistance status of Mycobacterium tuberculosis in Austria 1992 and 1993].
    Stauffer F; Jaksch G
    Wien Klin Wochenschr; 1995; 107(15):470-1. PubMed ID: 7676686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology.
    Tudó G; González J; Obama R; Rodríguez JM; Franco JR; Espasa M; Simarro PR; Escaramís G; Ascaso C; García A; Jiménez de Anta MT
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):15-22. PubMed ID: 14974741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A; Anagonou S; Gninafon M; Lambregts K; Boulahbal F
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiological survey on the trend of drug resistance of Mycobacterium tuberculosis complex in Macao during 2001 to 2005].
    Cheong SV; Lao UL
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):411-4. PubMed ID: 17673010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensively drug-resistant tuberculosis: are we prepared enough?
    Bhan A
    Natl Med J India; 2007; 20(3):158-9. PubMed ID: 17874481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.